Restricted accessResearch articleFirst published online 2015-12
A prospective cohort study investigating readmission,symptom attribution and psychological health within six months of primary percutaneous coronary intervention
Following primary percutaneous coronary intervention (PPCI) for ST-elevation myocardial infarction, some patients are readmitted with potential ischaemic heart disease symptoms. This study investigated the proportion of PPCI patients readmitted due to potential ischaemic heart disease symptoms within six months, and the cause of symptoms and associated factors.
Methods and results:
A prospective cohort study included consecutive PPCI patients. Baseline variables incorporated the Global Registry of Acute Coronary Events, the Charlson Comorbidity Index and self-report measures ENRICHD Social Support Inventory, Seattle Angina Questionnaire (SAQ) and Hospital and Anxiety and Depression Scale (HADS). At six months, repeat SAQ, HADS and readmission data were collected. Of 202 PPCI patients (mean 59.7 years (SD 13.9), 75.7% male), 38 (18.8%; 95% confidence interval 14.0–24.8%) were readmitted due to potential ischaemic heart disease symptoms (16 cardiac events, 22 indeterminate diagnosis) at six months. Mean HADS anxiety scores were higher for the readmission compared with the non-readmission group (baseline 9.5 vs. 7.1, p=0.006; six months 9.4 vs. 6.0, p<0.001). Angina symptoms were stable and infrequent throughout for both groups. Logistic regression modelling, including predictors HADS anxiety, SAQ angina stability, SAQ angina frequency, the Global Registry of Acute Coronary Events and the Charlson Comorbidity Index, determined HADS anxiety as a predictor of readmission with adjusted odds ratio of 1.12 (95% confidence interval 1.03–1.22, p=0.008).
Conclusion:
One in six patients were readmitted due to potential ischaemic heart disease symptoms, with the largest proportion receiving an indeterminate readmission diagnosis. Elevated levels of anxiety at baseline were predictive of readmission with potential ischaemic heart disease symptoms at six months.
DammenTArnesenHEkebergO. Psychological factors, pain attribution and medical morbidity in chest-pain patients with and without coronary artery disease. Gen Hosp Psychiatry2004; 26463-469.
2.
MayouRGillDThompsonD. Depression and anxiety as predictors of outcome after myocardial infarction. Psychosom Med2000; 62: 212-219.
3.
RosEArmengolXGrandeL. Chest pain at rest in patients with coronary artery disease myocardial ischemia, esophageal dysfunction, or panic disorder?Dig Dis Sci1997; 42: 1344-1353.
4.
LambertLBrownKSegalEBrophyJ. Association between timeliness of reperfusion therapy and clinical outcomes in ST-elevation myocardial infarction. JAMA2010; 303: 2148-2155.
5.
AntmanEMHandMArmstrongPW. 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients with ST-elevation Myocardial Infarction: A report of the ACC/AHA Task Force on Practice Guidelines. Circulation2008; 117: 296-329.
6.
OrtolaniPMarzocchiAMarrozziniC. Long-term effectiveness of early administration of glycoprotein IIb/IIIa agents to real-world patients undergoing primary percutaneous interventions: Results of a registry study in an ST-elevation myocardial infarction network. Eur Heart J2009; 30: 33-43.
7.
GraceSAbbeySIrvineJ. Prospective examination of anxiety persistence and its relationship to cardiac symptoms and recurrent cardiac events. Psychother Psychosom2004; 73: 344-352.
8.
GraceSAbbeySPintoR. Longitudinal course of depressive symptomatology after a cardiac event: Effects of gender and cardiac rehabilitation. Psychosom Med2005; 67: 52–58.
9.
AustinDAdamZShomeJ. Route of admission in STEMI: Do patients who present directly to a PCI-capable hospital differ from inter-hospital transfers?Heart2011; 97(Suppl. 1): A5.
10.
JakobsenLNiemannTPedersenNT. Comparison of primary percutaneous coronary intervention in real-world populations versus clinical trial populations. Am J Cardiol2010; 105: 1684-1691.
11.
MehranRLanskyAJWitzenbichlerB. Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial. Lancet2009; 374: 1149-1159.
12.
Frasure-SmithNLesperanceFTalajicM. Depression following myocardial infarction. Impact on 6-month survival. JAMA1993; 270: 1819-1825.
13.
LaneDCarrollDRingC. Effects of depression and anxiety on mortality and quality-of-life 4 months after myocardial infarction. J Psychosom Res2000; 49: 229-238.
14.
CossetteSFrasure-SmithNLesperanceF. Clinical implications of a reduction in psychological distress on cardiac prognosis in patients participating in a psychosocial intervention program. Psychosom Med2001; 63: 257-266.
15.
DeVonHARyanCJOchsAL. Symptoms across the continuum of acute coronary syndromes: Differences between women and men. Am J Crit Care2008; 17: 14-25.
16.
SampsonFO’CathainAGoodacreS. Feeling fixed and its contribution to patient satisfaction with primary angioplasty: A qualitative study. Eur J Cardiovasc Nurs2009; 8: 85-90.
17.
KeeleyEBouraJGrinesC. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomised trials. Lancet2003; 361: 13-20.
18.
AstinFClossSJMcLenachanJ. Primary angioplasty for heart attack: Mismatch between expectations and reality?J Adv Nurs2009; 65: 72-83.
19.
AstinFClossSJMcLenachanJ. The information needs of patients treated with primary angioplasty for heart attack: An exploratory study. Patient Educ Couns2008; 73: 325-332.
GUSTO IIb Angioplasty Substudy Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med1997; 336: 1621-1628.
22.
StoneGGrinesCCoxD. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med2002; 346: 957-966.
23.
FoxKAADabbousOHGoldbergRJ. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: Prospective multinational observational study (GRACE). BMJ2006; 25; 333: 1091-1094.
24.
CharlsonMEPompeiPAlesKL. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis1987; 40: 373-383.
25.
National Institute for Health and Clinical Excellence. Unstable angina and NSTEMI: The early management of unstable angina and non-ST-segment-elevation myocardial infarction, www.nice.org.uk/guidance/CG94 (2010, accessed 1 May 2010).
26.
National Institute for Health and Clinical Excellence. Chest pain of recent onset: Assessment and diagnosis of recent onset chest pain or discomfort of suspected cardiac origin, www.nice.org.uk/guidance/CG95 (2010, accessed 1 May 2010).
27.
DeatonCThouraniV. Patients with type 2 diabetes undergoing coronary artery bypass graft surgery: Predictors of outcomes. Eur J Cardiovasc Nurs2009; 8: 48-56.
ZigmondASnaithR. The Hospital Anxiety and Depression Scale. Acta Psych Scand1983; 67: 361-370.
30.
MortensenOBjornerJOldenburgB. Health-related quality of life one month after thrombolysis or primary PCI in patients with ST-elevation infarction. A DANAMI-2 sub-study. Scand Cardiovasc J2005; 39: 206–212.
31.
StrikJJMHHonigALousbergR. Sensitivity and specificity of observer and self-report questionnaires in major and minor depression following myocardial infarction. Psychosomatics2001; 42: 423-428.
32.
SpertusJAWinderJADewhurstTA. Development and evaluation of the Seattle Angina Questionnaire: A new functional status measure for coronary artery disease. J Am Coll Cardiol1995; 25: 333–341.
33.
NorrisCSaundersLGhaliW. Health-related quality of life outcomes of patients with coronary artery disease treated with cardiac surgery, percutaneous coronary intervention or medical management. Can J Cardiol2004; 20: 1259-1266.
34.
OesterleSNSanbornTAAliN. Percutaneous transmyocardial laser revascularisation for severe angina: The PACIFIC randomised trial. Lancet2000; 356: 1705-1710.
35.
MitchellPHPowellLBlumenthalJ. A short social support measure for patients recovering from myocardial infarction: The ENRICHD Social Support Inventory. J Cardiopulm Rehabil2003; 23: 398-403.
36.
McHorneyCAWareJEJrRaczekAE. The MOS 36-Item Short-form health survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care1993; 31: 247-263.
37.
VaglioJConardMPostonW. Testing the performance of the ENRICHD Social Support Instrument in cardiac patients. Health Qual Life Outcomes2004; 2, http://www.hqlo.com/content/2/1/24 (accessed 14 December 2006).
38.
DickensCMMcGowanLPercivalC. Lack of a close confidant, but not depression, predicts further cardiac events after myocardial infarction. Heart2004; 90: 518-522.
39.
BerkmanLFBlumenthalJBurgM.; Enhancing Recovery in Coronary Heart Disease Patients Investigators (ENRICHD). Effects of treating depression and low perceived social support on clinical events after myocardial infarction. The enhancing recovery in coronary heart disease patients (ENRICHD) randomized trial. J Am Med Assoc2003; 289: 3106-3116.
40.
PeduzziPConcatoJKemperE. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol1996; 49: 1373-1379.
41.
VittinghoffEMcCullochCE. Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol2007; 165: 710-718.
42.
NagelkerkeNJD. A note on a general definition of the coefficient of determination. Biometrika1991; 78: 691-692.
43.
StrikJJMHDenolletJLousbergR. Comparing symptoms of depression and anxiety as predictors of cardiac events and increased health care consumption after myocardial infarction. J Am Coll Cardiol2003; 42: 1801-1807.
44.
RoestAMMartensEJDenolletJ. Prognostic association of anxiety post myocardial infarction with mortality and new cardiac events: A meta-analysis. Psychosom Med2010; 72: 563-569.
